You can now search for information using our newly improved search bar below or search for Trust wide or divisional news.
Page results
-
In light of the rising cost of living, financial wellbeing is now more important than ever. Prices are rising, taxes are increasing and worries about costs are ever growing. MoneyHelper is a…
-
Mersey Care has invested in an Advanced Clinical Practice team that sits within the Executive Nursing and Therapies team across the Trust. We have two ACP Leads within the Trust who focus on Education…
-
The origin of the word ‘blog’ is as an abbreviation for ‘web-log’ – that is, an online diary. Our blogs are being developed to communicate informally with our…
-
The Trust's Medication Safety Officer (MSO) is responsible for overseeing medicine safety issues and ensuring that any problems are highlighted and communicated within and externally to the Trust.…
-
Established rapidly in response to the pandemic, the Long COVID Service has provided essential care for patients with prolonged and complex physical and psychological symptoms of COVID that have…
-
Information on CQC registration
File results
-
MMP50 Rapid Tranquilisation
This document provides Trust staff working on wards with guidance about the use of Rapid Tranquillisation. It determines the main provisions of appropriate use of Rapid Tranquillisation, use of associated medication and the roles and responsibilities of staff to ensure a consistently safe and effective approach to the use of rapid tranquillisation for the shortterm management of violence and aggression; ensuring that patients are informed at each stage of the process and if treatment is necessary ensures that individuals are treated with dignity and respect.
-
12. Rapid Tranquillisation Procedure - June 22
-
2. Rapid Tranquillisation Procedure - June 22
-
Rapid Tranquilisation Policy
-
MMP66 Safe Administration of subcutaneous Insulin in Community and Inpatient Settings
This procedure is designed to give clarity and guidance around assessment, treatment and management of patients within the community or inpatient setting who require the administration of subcutaneous insulin.